Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye Tracking as a Biomarker of Cannabis Effects
NCT04100590Phase 2Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial comparing Active Cannabis with Placebo Cannabis (2 arms). Primary endpoint: Convergence. Started Oct 2019; status: terminated.
02
Drugs
cannabis
Beyond the preview
Go deeper on NCT04100590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04100590.